Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Nihon Shokakibyo Gakkai Zasshi ; 108(6): 969-77, 2011 Jun.
Article in Japanese | MEDLINE | ID: mdl-21646765

ABSTRACT

A 78-year-old man presented with upper abdominal pain. He underwent an abdominal computed tomography scan which revealed irregularly shaped mass lesions in the mesentery and in the pancreatic head and body. The mass lesions were suspected to be pancreatic cancer with peritoneal dissemination and a surgical biopsy was performed. Histologic studies revealed lymphoplasmacytic sclerosing pancreatitis with significant infiltration of IgG4-positive plasma cells. His serum IgG4 level was 223 mg/dl. Findings from histologic and serum studies were compatible with IgG4-related sclerosing disorders. The mass lesions responded to steroid therapy and disappeared. The difficulty in making a definitive diagnosis is discussed.


Subject(s)
Immunoglobulin G/analysis , Mesentery/pathology , Pancreatic Diseases/pathology , Sclerosis/pathology , Aged , Autoimmune Diseases/pathology , Humans , Male , Pancreatitis/pathology
2.
Nihon Shokakibyo Gakkai Zasshi ; 103(6): 643-9, 2006 Jun.
Article in Japanese | MEDLINE | ID: mdl-16800287

ABSTRACT

The patient was a 58-year-old female. Though she had been in good health, increased hepatobiliary enzymes were detected in a health examination. She visited our hospital for close examination. The serum IgG4 level was normal, but ERCP and MRCP showed band-like stricture and beaded appearance of the bile ducts. A diagnosis of primary sclerosing cholangitis (PSC) was made. Since hyperlipidemia was also observed, oral administration of bezafibrate (400mg/day) alone was performed as the initial treatment, and transaminase, ALP, and GGT rapidly decreased. These results suggested that the initial administration of bezafibrate alone is effective against PSC.


Subject(s)
Bezafibrate/administration & dosage , Cholangitis, Sclerosing/drug therapy , Hypolipidemic Agents/administration & dosage , Administration, Oral , Cholangitis, Sclerosing/complications , Female , Humans , Hyperlipidemias/complications , Hyperlipidemias/drug therapy , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...